Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylmethanesulfonic Acid SCHEMBL28064943 | 0.87 | CA2 (0.54) | CA1CA2MMP1MMP2MMP9 | |
| Phenylmethanesulfonic Acid SCHEMBL28194151 | 0.87 | PRSS1 (0.54) | CA1CA2MMP1MMP2MMP9 | |
| Phenylmethanesulfonic Acid SCHEMBL28294303 | 0.87 | CA2 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| Phenylmethanesulfonic Acid SCHEMBL127384 | 0.87 | CA2 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| Phenylmethanesulfonic Acid SCHEMBL30217949 | 0.87 | CA2 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| Phenylmethanesulfonic Acid SCHEMBL1749 | 0.87 | CA2 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| Pyridine SCHEMBL31212672 | 0.85 | KMT2A (0.46) | SMN1; SMN2KMT2AALDH1A1HPGDLMNA | |
| Phenylmethanesulfonic Acid SCHEMBL7116 | 0.85 | CA2 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| Phenylmethanesulfonic Acid SCHEMBL1073102 | 0.85 | CA2 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| Phenylmethanesulfonic Acid SCHEMBL9806419 | 0.85 | CA2 (0.56) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1529777-B1 | Process and oxazolidine intermediate for the synthesis of taxanes | INDENA SPA (IT) | 2007-01-03 | — | — | EP | claimed |
| EP-1490332-B1 | METHOD OF SYNTHESIZING 1-ALPHA-HYDROXY-2-METHYLENE-19-NOR-HOMOPREGNACALCIFEROL | WISCONSIN ALUMNI RES FOUND (US) | 2006-11-29 | — | — | EP | claimed |
| EP-0577302-B1 | Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates | LILLY CO ELI (US) | 1997-07-16 | — | — | EP | claimed |
| EP-0640614-B1 | Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates | LILLY CO ELI (US) | 1996-12-04 | — | — | EP | claimed |
| EP-4584269-A1 | PYRAZOLO[1,5-A]PYRIDINE AND IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS FGFR3 INHIBITORS FOR THE TREATMENT OF CANCER | Eli Lilly and Company (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054808-A1 | PYRAZOLO[1,5-A]PYRIDINE AND IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS FGFR3 INHIBITORS FOR THE TREATMENT OF CANCER | ELI LILLY AND COMPANY (US) | 2024-03-14 | — | — | WO | disclosed |
| CN-115721628-A | PH/GGT enzyme dual-response type modified glucan self-assembly and high-throughput microfluidic preparation method thereof | 中国科学院上海硅酸盐研究所 | 2023-03-03 | — | — | CN | disclosed |
| EP-2816049-B1 | ß-ketophosphonic acids and all dental materials based thereon | IVOCLAR VIVADENT AG (LI) | 2018-05-30 | — | — | EP | disclosed |
| EP-2602856-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | WAKO PURE CHEM IND LTD (JP) | 2017-02-22 | — | — | EP | disclosed |
| CN-104211620-B | The autofrettage of bi-quaternary ammonium salt and its intermediate | Wako-chem Industries Co., Ltd. (JP) | 2016-05-25 | — | — | CN | disclosed |
| US-9257720-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-09 | — | — | US | disclosed |
| EP-2821395-A2 | Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery | Wako Pure Chemical Industries, Ltd. (JP) | 2015-01-07 | — | — | EP | disclosed |
| EP-0496700-B1 | Diphosphines containing silane groups, immobilized diphosphines and their use as hydrogenation catalysts | CIBA GEIGY AG (CH) | 1996-03-06 | — | — | EP | disclosed |
| EP-0565317-A1 | (2-(2-hydroxy-2 phenylethylamino)ethoxy) phenyl derivatives, processes and intermediates for their preparation, pharmaceutical compositions containing them and their use as Beta-3-adrenoceptor agonists | ZENECA LIMITED (GB) | 1993-10-13 | — | — | EP | disclosed |
| EP-0503548-A1 | Cyclic urea derivatives, medicaments contaning them and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1992-09-16 | — | — | EP | disclosed |
| EP-0496700-A1 | Diphosphines containing silane groups, immobilized diphosphines and their use as hydrogenation catalysts | CIBA-GEIGY AG (CH) | 1992-07-29 | — | — | EP | disclosed |
| EP-0187847-A1 | PROCESS FOR THE MANUFACTURE OF 6$g(A)-METHYL STEROIDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-07-23 | — | — | EP | disclosed |
| WO-1986000907-A1 | PROCESS FOR THE MANUFACTURE OF 6ALPHA-METHYL STEROIDS | SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) | 1986-02-13 | — | — | WO | disclosed |
| EP-0164298-A2 | 6-Alpha-methyl-D-homo-corticoids | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-12-11 | — | — | EP | disclosed |
| EP-0149222-A2 | 6-Alpha, 16 alpha-dimethyl corticoids | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-07-24 | — | — | EP | disclosed |